Smith Group Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-12,140
| Closed | -$84K | – | 534 |
|
|
2015
Q3 | $84K | Buy |
12,140
+1,700
| +16% | +$11.8K | ﹤0.01% | 275 |
|
|
2015
Q2 | $103K | Buy |
10,440
+890
| +9% | +$8.78K | ﹤0.01% | 244 |
|
|
2015
Q1 | $85K | Buy |
9,550
+2,300
| +32% | +$20.5K | ﹤0.01% | 303 |
|
|
2014
Q4 | $64K | Hold |
7,250
| – | – | ﹤0.01% | 285 |
|
|
2014
Q3 | $50K | Buy |
7,250
+4,100
| +130% | +$28.3K | ﹤0.01% | 255 |
|
|
2014
Q2 | $17K | Hold |
3,150
| – | – | ﹤0.01% | 315 |
|
|
2014
Q1 | $14K | Sell |
3,150
-2,760
| -47% | -$12.3K | ﹤0.01% | 309 |
|
|
2013
Q4 | $30K | Hold |
5,910
| – | – | ﹤0.01% | 268 |
|
|
2013
Q3 | $30K | Buy |
+5,910
| New | +$30K | ﹤0.01% | 268 |
|